An international leader in advanced medical technology solutions, KDA powers healthcare innovation in a humane, safe and secure manner.
KDA develops digital and artificial intelligence solutions, specialized medical education and training, consulting, and replacement of professional resources in the health sector.
KDA takes on global health challenges on every continent.
December 2022. KDA completed the acquisition of Covapharm Inc and its technologies, L’Apothicaire, the digital pharmacotherapy guide, as well as L’Assistant, a digital tool made to optimize the pharmaceutical treatment of patients.
KDA signed a distribution partnership for its KRx platform with three major specialized software service companies thereby providing access to more than 5,000 dentists in Quebec and 25,000 throughout Canada.
December 2022. KDA completed a promising tour in Hong Kong with its partner Cavendish Investments Corporation. The response in Hong Kong, with more than 15,000 physicians, was very favorable for KRx and the possibility of integrating Adherize+, while e-prescription has not yet entered the market.
Join an experienced international team pioneering the development of ground-breaking solutions that are transforming global healthcare systems.